Sarepta Therapeutics (NASDAQ: SRPT) options priced for movement into expected FDA decision

September 14, 2016 6:11 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Sarepta Therapeutics (NASDAQ: SRPT) is recently up $3.35 to $28.95 in the premarket on hope for a decision on the delayed FDA decision regarding eteplirsen. September call option implied volatility is at 131, September weekly is at 147, October is at 187; compared to its 52-week range of 68 to 399.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Options, Trader Talk

Related Entities

Options

Add Your Comment